Skip to main content

Table 2 Costs and utilities used in the economic model

From: The cost-effectiveness of changes to the care pathway used to identify depression and provide treatment amongst people with diabetes in England: a model-based economic evaluation

Unit costs
 GP appointment £37 PSSRU [40]
 Annual review £397 NAO [41]
 Opportunistic screening for depression £2 Assumption
 Antidepressants (daily costs) £0.073 Tosh et al. [16]
 IAPT per session £88 Tosh et al. [16]
Diabetes-related complications*
 Diabetes — no complications £252 Clarke et al. [32]
 CHF — year of event / subsequent years £3,559 / £1,01 Clarke et al. [32]
 IHD — year of event / subsequent years £3,139 / £790 Clarke et al. [32]
 MI — year of event / subsequent years £6,522 / £744 Clarke et al. [32]
 Stroke — year of event / subsequent years £3,793 / £399 Clarke et al. [32]
 Blindness — year of event / subsequent years £1,397 / £450 Clarke et al. [32]
 Ulcer — year of event / subsequent years £1,855 / £21 Ghatnekar et al. [42]
 Amputation — year of event / subsequent years £13,556 / £481 Clarke et al. [32]
 Renal failure — year of event / subsequent years £34,806 / £34,806 NICE STA for dapagliflozin [43]
 Severe hypoglycaemia £390 NICE STA for dapagliflozin [43]
Health state utilities Value References
Baseline 0.807 Alva et al. [27]
Decrements
 MI (year before) −0.065 Alva et al. [27]
 MI (prior history) 0.008 Alva et al. [27]
 IHD −0.028 Alva et al. [27]
 Stroke −0.165 Alva et al. [27]
 Heart Failure −0.101 Alva et al. [27]
 Amputation −0.172 Alva et al. [27]
 Blindness 0.033 Alva et al. [27]
 Renal failure −0.263 Klarenbach et al. [29]
 Foot ulcer −0.016 Sollie et al. [28]
 Severe Hypoglycaemia −0.00186 Marrett et al. [30]
 Minor depression 0 Kaltenthaler et al. [31]
 Major depression −0.3 Kaltenthaler et al. [31]
 Effect of being on depression treatment on the decrement for major depression; responders only (multiplier) x0.5 Assumption
  1. *Uplifted to 2013 prices
  2. GP General practitioner, MI myocardial infarction, IHD ischaemic heart disease